# Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes

> **NCT04776031** · NA · COMPLETED · sponsor: **Lutronic Vision, Inc** · enrollment: 31 (actual)

## Conditions studied

- Early Age Related Macular Degeneration (Disorder)

## Interventions

- **DEVICE:** R:GEN Laser System

## Key facts

- **NCT ID:** NCT04776031
- **Lead sponsor:** Lutronic Vision, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-15
- **Primary completion:** 2023-03-14
- **Final completion:** 2023-03-14
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04776031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04776031, "Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04776031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*